DE
Stocks › Europe › SMI › Galderma

Galderma Stock Forecast & Price Target

Ticker GALD ISIN CH1335392721
230.56USD
+$1.12 (+0.49%)today
Real-time As of Nov 11, 2026, 9:57 AM ET
Quantum Forecast Range band

Galderma Price Target 2026

The Quantum Forecast sees a price target of $239.28 (+3.8%) for Galderma in about one month (by Dec 10, 2026).

Quantum Forecast price targets by time frame, calculated from the current price of $230.56. Click to see the forecast in the chart.

Time framePrice targetChangeRange band
1 monthby Dec 10, 2026 · Chart 6M$239.28 ▲ +3.8% $218.97 – $259.59
2 monthsby Jan 8, 2027 · Chart 1Y$239.41 ▲ +3.8% $210.18 – $268.65
5 monthsby Apr 21, 2027 · Chart 3Y$215.91 ▼ −6.4% $170.56 – $261.25

Galderma Forecast for Today and Tomorrow

In the short term, the Quantum Forecast sees Galderma at $230.65 (+0.04%) today around 10:45 AM ET and at $230.33 (−0.10%) tomorrow around 2:30 AM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart

Galderma Stock 2026: Price Performance

Galderma stock has gained 12.4% since the start of 2026 and currently trades at $230.56 (as of Nov 11, 2026). Over the same period the SMI is up 13.4%, putting the stock 1.1 percentage points behind the index. Over the past 52 weeks the price ranged between $173.55 and $240.81; it is currently 4.3% below its high of Nov 5, 2026.

Galderma Forecast 2027

Over a horizon of roughly 5 months (until about Apr 2027), the Quantum Forecast sees a price target of $215.91 for Galderma – −6.4% from today. The range band runs from $170.56 – $261.25: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart

Community Forecast for Galderma

There are no user forecasts for Galderma yet – be the first to make one.

Make your own forecast

About Galderma

Galderma is a pure-play dermatology company headquartered in Zug, Switzerland. It was established in 1981 as a joint venture between Nestlé and L'Oréal. In 2019 Nestlé sold Galderma to an investor group led by EQT, and the company went public in Zurich in 2024. Its business is organized into three areas: injectable aesthetics, dermatological skin care and therapeutic dermatology.

Aesthetics includes hyaluronic acid fillers such as Restylane, the collagen stimulator Sculptra and the neuromodulator Dysport. In skin care, Cetaphil is the best-known brand, complemented by Alastin. The prescription business includes Nemluvio for atopic dermatitis and prurigo nodularis. Customers include dermatologists, aesthetic clinics, pharmacies, drugstores and online retailers, with the United States as the most important market. The rollout of Nemluvio and consumer demand for aesthetic treatments are key themes for the stock. Galderma is listed on the SIX Swiss Exchange under the ticker GALD and is a member of the SMI.

The current price of Galderma stock is $230.56 (+0.49% vs. the previous close). In today's trading the high was $231.44 and the low $226.39.

Index SMIRegion Europe Currency USD Price history since 2024

How the Quantum Forecast works

  1. Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.

  2. Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.

  3. Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.

  4. Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.

The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence

Frequently Asked Questions about Galderma Stock

What is the Galderma stock forecast?

The Quantum Forecast expects Galderma to reach $239.28 in about one month (by Dec 10, 2026), a change of +3.8% from the current price of $230.56. Over roughly 5 months (by Apr 2027) the price target is $215.91 (−6.4%).

What is the Galderma stock price target?

Quantum Forecast price targets by time frame: 1 month $239.28 (+3.8%), 2 months $239.41 (+3.8%), 5 months $215.91 (−6.4%). The range band shows the typical fluctuation around these targets.

Will Galderma stock go up or down?

In the short term the Quantum Forecast points up (+3.8% over one month). No forecast is certain – it is based on historical prices and statistical analysis.

How is the Quantum Forecast computed?

Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.

Can I make my own forecast for Galderma?

Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.

WelcomeSave your watchlist and forecasts across all your devices

My stuff

WatchlistSaved stocks Price alertssoon

Display

Sprache · Language

Deutsch